U.S. market Closed. Opens in 1 day 6 hours 47 minutes

CTNM | Contineum Therapeutics, Inc. Class A Common Stock Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 13.92 - 14.82
52 Week Range 12.33 - 22.00
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 136,522
Average Volume 77,560
Shares Outstanding 25,777,791
Market Cap 363,209,075
Sector Healthcare
Industry Biotechnology
IPO Date N/A
Valuation
Profitability
Growth
Health
P/E Ratio -39.14
Forward P/E Ratio N/A
EPS -0.36
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 31
Country USA
Website CTNM
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. Its lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and progressive multiple sclerosis (MS). The company also develops PIPE-307, a novel, small molecule selective inhibitor of the muscarinic type 1 M1 receptor to treat depression and relapse remitting MS; and CTX-343, a peripherally-restricted LPA1R antagonist. Contineum Therapeutics, Inc. was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. The company was incorporated in 2009 and is headquartered in San Diego, California.
*Chart delayed
Analyzing fundamentals for CTNM we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very strong. For more detailed analysis please see CTNM Fundamentals page.

Watching at CTNM technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on CTNM Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙